Sarepta Therapeutics, Inc. (SRPT)
18.88
+0.29
(+1.56%)
USD |
NASDAQ |
Feb 20, 16:00
18.58
-0.30
(-1.59%)
After-Hours: 20:00
Sarepta Therapeutics SG&A Expense (Quarterly) : 91.89M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 46.02M |
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |
| REGENXBIO, Inc. | 20.25M |
| Keros Therapeutics, Inc. | 10.13M |